SCHEMBL2467414

SCHEMBL2467414

CN(C)CCCN(C(=O)O)c1cccc(Cn2nc(-c3cccc(F)c3F)ccc2=O)c1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 19/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2466876 0.89 MET (0.50) MET
SCHEMBL2468137 0.89 MET (0.53) MET
SCHEMBL2467459 0.86 MET (0.53) MET
SCHEMBL2464380 0.86 MET (0.63) MET
SCHEMBL2472319 0.84 MET (0.51) MET
SCHEMBL2467270 0.84 MET (0.53) MET
SCHEMBL2468334 0.84 MET (0.63) MET
SCHEMBL2672462 0.82 MET (0.63) MET
SCHEMBL2468886 0.82 MET (0.50) MET
SCHEMBL2470648 0.81 MET (0.45) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173653-B2 Pyridiazinone derivatives for the treatment of tumours MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2012-05-08 — — US claimed
EP-1960370-B1 PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT MERCK PATENT GMBH (DE) 2011-10-05 — — EP claimed
Send feedback